Boryung Pharm’s ‘Kanarb Tab’ recording highest manufacturing performance last year among Korean new drugs

Among pharmaceutical products approved as new drug developed in Korea, a product which recorded the highest sales was ‘Kanarb Tab,’ a Boryung Pharm’s antihypertensive.

In addition, among the 26 new drugs developed in Korea, there were only 5 products with a manufacturing performance more than KRW 10 billion in a year.

The Ministry of Food and Drug Safety announced the last year’s total manufa...